Editor's Note: This story is a supplement to the feature "Solving the Mystery of the Vanishing Bees."
Overview
Overview
A Miami-based biotechnology start-up company called Beeologics is developing an antiviral drug that exploits an ancient immune mechanism called RNA interference. Cells in most animals and plants use short- interfering RNA (siRNA) segments to inhibit the formation of viral proteins; here siRNA designed to target IAPV would be fed to colonies as part of double-stranded RNA mixed into a syrup.
See what we're tweeting about
DNLee5 #DispatchesDNLee: best decision I made for this trip was increasing my budget for assistants. I was feeling too... http://t.co/1wkXqry2Vj
eyeforscience Yes! RT @EamesEra RT @corrinrenee Dear all websites. My day phone is my evening phone is my home phone is my cell phone. Sincerely, 2013
MRAKdesign Cool coal shoot cover. lrgendron http://t.co/4SrwRBNoDw
Deadline: Jun 30 2013
Reward: $1,000,000 USD
This is a Reduction-to-Practice Challenge that requires written documentation and&
Deadline: Jul 25 2013
Reward: Varies
This challenge provides an opportunity for Solvers to build a web-based or mobile “app” to explore data relationships in scholarly conte
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
Comments
Add Comment